Posaconazole in lung transplant recipients: use, tolerability, and efficacy.
about
Complications of invasive mycoses in organ transplant recipients.Fungal Infections After Lung Transplantation.Posaconazole tablets in real life lung transplantation: impact on exposure, drug-drug interactions and drug management in lung transplanted patients, including cystic fibrosis.Posaconazole liquid vs tablet formulation in lung transplant recipients.Single-centre study of therapeutic drug monitoring of posaconazole in lung transplant recipients: factors affecting trough plasma concentrations.
P2860
Posaconazole in lung transplant recipients: use, tolerability, and efficacy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Posaconazole in lung transplant recipients: use, tolerability, and efficacy.
@en
type
label
Posaconazole in lung transplant recipients: use, tolerability, and efficacy.
@en
prefLabel
Posaconazole in lung transplant recipients: use, tolerability, and efficacy.
@en
P2093
P2860
P356
P1476
Posaconazole in lung transplant recipients: use, tolerability, and efficacy.
@en
P2093
P2860
P304
P356
10.1111/TID.12497
P50
P577
2016-01-19T00:00:00Z